The Russian Gamaleya Institute, which developed the Sputnik V coronavirus vaccine, has applied for an emergency use permit in the Philippines.
The Moscow-based company filed its lawsuit Thursday, according to the Philippines News Agency.
A day earlier, Gamaleya withdrew his bid to hold clinical trials in the country, according to CNN-affiliated CNN.
Gamaleya is the third vaccine manufacturer – along with Pfizer-BioNTech and Oxford-AstraZeneca – to apply for an emergency use permit in the Philippines.
It usually takes the Philippine Food and Drug Administration 21 days to decide whether to use a drug or vaccine in the country, according to CNN Philippines.
Last November, Russia reported that the Sputnik V vaccine was at least 91.4% effective and could be more than 95% effective, according to data from its Phase 3 tests.